StemBioSys

Stem Bio Sys

Biotechnology, 3463 Magic Dr, San Antonio, Texas, 78229, United States, 11-50 Employees

stembiosys.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: +12*********

Who is STEMBIOSYS

StemBioSys is located in San Antonio, Texas and proximate to the University of Texas Health Science Center San Antonio (UTHSC-SA) from which we have licensed proprietary and disruptive te...

Read More

map
  • 3463 Magic Dr, San Antonio, Texas, 78229, United States Headquarters: 3463 Magic Dr, San Antonio, Texas, 78229, United States
  • 2010 Date Founded: 2010
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $10 Million to $25 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8731 | NAICS Code: 541715 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from STEMBIOSYS

StemBioSys Org Chart and Mapping

Employees

Travis Block

Chief Technology Officer

Arvelle Daigle

Office Manager/Executive Assistant

Iris Flores

Senior Director of Global Sales

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding StemBioSys

Answer: StemBioSys's headquarters are located at 3463 Magic Dr, San Antonio, Texas, 78229, United States

Answer: StemBioSys's phone number is +12*********

Answer: StemBioSys's official website is https://stembiosys.com

Answer: StemBioSys's revenue is $10 Million to $25 Million

Answer: StemBioSys's SIC: 8731

Answer: StemBioSys's NAICS: 541715

Answer: StemBioSys has 11-50 employees

Answer: StemBioSys is in Biotechnology

Answer: StemBioSys contact info: Phone number: +12********* Website: https://stembiosys.com

Answer: StemBioSys is located in San Antonio, Texas and proximate to the University of Texas Health Science Center San Antonio (UTHSC-SA) from which we have licensed proprietary and disruptive technology for the enhanced isolation, growth and delivery of stem cells or other difficult to culture cells for research, diagnostic and therapeutic applications. We are currently focused on scale-up activities for our patented core technology, CELLvoTM Matrix and our initial product launch to the stem cell research market in mid-2015. Build-out of our cGMP facility with partner BioBridge Global is complete and we have begun to explore therapeutic applications and business relationships with potential partners for other, next generation, product offerings from this versatile platform technology. Our core novel technology platform is an advanced stem cell culture system CELLvoTM Matrix. CELLvo MatrixTM replicates the 3-dimensional home in which stem cells naturally reside and proliferate. Stem cells grown in BM-HPMETM remain small, proliferative and undifferentiated. Our unique technology enables users to isolate and grow stem cells and other difficult to culture cells from a variety of sources including but not limited to adipose, bone marrow and umbilical cord blood/tissue and cancer cells. Stem cells are the future of medicine. We are the future of stem cells. We will build value for our shareholders by perfecting and focusing on the use of our disruptive stem cell technology platforms, know-how and intellectual property for the treatment of meaningful medical disorders. We will establish the facilities, expertise, discipline and culture required to assure our patients, physicians, researchers and partners that everything we do will conform to the highest standards of quality.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access